LC-MS/MS method development of aflibercept using Fab-selective proteolysis nSMOL technology

Postery | 2020 | ShimadzuInstrumentace

LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC/QQQ

Zaměření

Klinická analýza

Výrobce

Shimadzu

Přejít do knihovny Zobrazit PDF

PDF verze ke stažení a čtení

Podobná PDF

Shimadzu Solutions for Biopharmaceutical - Application Notebook

2018|Shimadzu|Příručky

C10G-E054 Solutions for Biopharmaceutical Application Notebook First Edition: December, 2017 © Shimadzu Corporation, 2017 Solutions for Biopharmaceutical Index Application Notebook Bioanalysis LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Trastuzumab analysis nSMOL, which enables selective proteolysis of the…

Klíčová slova

acid, amino, antibody, glycan, nsmol, erexim, structure, news, aggregates, analysis, mrm, glycans, nucleic, sizer, confirmation

LCMS™ Bioanalysis of Antibody Drugs Using Fab- Selective Proteolysis nSMOL – Part 7 - Tocilizumab Analysis -

2020|Shimadzu|Aplikace

Application News No. C216 nSMOL Antibody BA Kit LCMS™ Bioanalysis of Antibody Drugs Using FabSelective Proteolysis nSMOL – Part 7 - Tocilizumab Analysis -  Introduction - Immunological Mechanism of  Application of LC-MS to Analysis of Antibody Tocilizumab is…